Haemophilia A News and Research

RSS
Hemophilia A is an X-linked, recessive, bleeding disorder caused by a deficiency in the activity of coagulation factor VIII. Affected individuals develop a variable phenotype of hemorrhage into joints and muscles, easy bruising, and prolonged bleeding from wounds. The disorder is caused by heterogeneous mutations in the factor VIII gene which maps to Xq28.
Santarus, Pharming Group submit Biologics License Application to FDA for RUCONEST

Santarus, Pharming Group submit Biologics License Application to FDA for RUCONEST

Study sheds light on stem cell technique for treatment of common bleeding disorder

Study sheds light on stem cell technique for treatment of common bleeding disorder

Biogen Idec, Sobi release data from rFVIIIFc and rFIXFc phase 3 trials on hemophilia

Biogen Idec, Sobi release data from rFVIIIFc and rFIXFc phase 3 trials on hemophilia

Researchers to develop new diagnostic tools and treatments for people with rare diseases

Researchers to develop new diagnostic tools and treatments for people with rare diseases

Interim results from Inspiration’s OBI-1 and IB1001 hemophilia clinical study

Interim results from Inspiration’s OBI-1 and IB1001 hemophilia clinical study

Positive results from Santarus and Pharming’s RUCONEST Phase III trial on HAE

Positive results from Santarus and Pharming’s RUCONEST Phase III trial on HAE

Hemostatic testing may explain heavy menstrual bleeding

Hemostatic testing may explain heavy menstrual bleeding

European collaboration to design a biomimetic bioartificial liver

European collaboration to design a biomimetic bioartificial liver

Study describes new method that synthesizes novel anti-HIV protein

Study describes new method that synthesizes novel anti-HIV protein

EvaluatePharma data shows poor R&D productivity measures both in quality, quantity

EvaluatePharma data shows poor R&D productivity measures both in quality, quantity

Grifols receives FDA approval for Alphanate to treat vCJD

Grifols receives FDA approval for Alphanate to treat vCJD

Inspiration presents IB1001 PK data for treatment of hemophilia B

Inspiration presents IB1001 PK data for treatment of hemophilia B

Inspiration presents IB1001 PK data at European haemophilia congress

Inspiration presents IB1001 PK data at European haemophilia congress

LFB receives positive review feedback for closing of Willfact 1000 IU Mutual Recognition Procedure

LFB receives positive review feedback for closing of Willfact 1000 IU Mutual Recognition Procedure

Octapharma initiates Human-cl rhFVIII clinical study for severe hemophilia A

Octapharma initiates Human-cl rhFVIII clinical study for severe hemophilia A

Octapharma sponsors symposium on inhibitors in Haemophilia A

Octapharma sponsors symposium on inhibitors in Haemophilia A

NKTreg white blood cells migrate into liver, suppress immune responses: Research

NKTreg white blood cells migrate into liver, suppress immune responses: Research

Pfizer to present results of hemophilia studies at WFH 2010 Congress

Pfizer to present results of hemophilia studies at WFH 2010 Congress

Bayer HealthCare to present BAY86-6150 rFVIIa Phase I clinical data at XXIX WFH International Congress

Bayer HealthCare to present BAY86-6150 rFVIIa Phase I clinical data at XXIX WFH International Congress

Simple blood test may help detect chromosomal abnormalities in developing foetus

Simple blood test may help detect chromosomal abnormalities in developing foetus